View Older Stories View More Recent Stories
-
SiTime Corporation Announces Pricing of Follow-on Public Offering
-
Kalvista Pharmaceuticals Inc (KALV) PT Raised to $55 at Roth Capital
-
Hexo Corp. (HEXO:CN) (HEXO) PT Raised to Cdn$4.50 at Roth Capital, After Acquiring Competitor
-
Pre-Open Stock Movers 02/17: (TUSK) (VSTM) (CSOD) Higher; (SHIP) (AFI) (KAR) Lower (more...)
-
Roth Capital Downgrades Kodiak Sciences Inc. (KOD) to Neutral
-
SolarEdge Technologies (SEDG) PT Raised to $380 at Roth Capital Ahead of Non-Solar Margin Improvement
-
Roth Capital Starts DiaMedica Therapeutics Inc. (DMAC) at Buy
-
United States Antimony Corporation Announces Closing of $14.3 Million Registered Direct Offering
-
KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
GT Biopharma Announces Closing of $23.7 Million Public Offering
-
GoldMining Announces Launch of Gold Royalty IPO and Application to List on the NYSE American
-
Bio-Path (BPTH) Announces Pricing of $13 Million Public Offering of Common Stock at $7.60/sh
-
Bio-Path Holdings, Inc. Announces Pricing of $13.0 Million Public Offering of Common Stock
-
New Age Beverages (NBEV) Announces $58 Million Private Placement of Common Stock
-
NewAge Announces $58 Million Private Placement
-
UPDATE: Roth Capital Starts CuriosityStream Inc. (CURI) at Buy
-
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
-
Limbach Holdings Closes Public Offering of Common Stock
-
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $34.3 Million
-
InvestorNewsBreaks – KemPharm Inc. (NASDAQ: KMPH) Secures $52.4M in Follow-on and $44M in Warrant Exchange Transaction
-
InvestorNewsBreaks – GT Biopharma Inc. (GTBP) Announces Public Offering Pricing, Uplists to Nasdaq Capital Market
-
Roth Capital Starts Applied DNA Sciences (APDN) at Buy
-
Phunware (PHUN) Prices 11.1M Share Common Stock Offering at $2.25/each
-
Phunware, Inc. Announces Pricing of Public Offering of Common Stock
-
Phunware (PHUN) Announces Proposed Common Share Offering
-
Phunware, Inc. Announces Proposed Public Offering of Common Stock
-
Dynatronics (DYNT) PT Raised to $2.10 at Roth Capital, Following Earnings
-
Orion Energy Systems (OESX) PT Lowered to $14 at Roth Capital, Following Earnings
-
LiveXLive Media (LIVX) PT Raised to $9 at Roth Capital; Takeover Could Be Near
-
GT Biopharma Announces Pricing of $23,650,000 Public Offering and Uplisting to The Nasdaq Capital Market
-
Roth Capital Starts PLBY Group, Inc. (PLBY) at Buy
-
KalVista Pharmaceuticals (KALV) Prices 5.375M Share Upsized Common Offering at $36/Sh
-
United States Antimony Corporation Announces $14.3 Million Registered Direct Offering
-
KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock
-
Moleculin Announces Full Exercise of Over-Allotment Option
-
SPI Energy Announces Closing of $14.7 million At-the-Market Registered Direct Offering
-
Fathom Holdings Inc. (FTHM) PT Raised to $52 at Roth Capital
-
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Secures $24.2M in Initial Public Offering
-
Roth Capital Downgrades Glu Mobile (GLUU) to Neutral, Following Acquisition
-
InvestorNewsBreaks – Harpoon Therapeutics Inc. (NASDAQ: HARP) Closes Underwritten $115M Follow-On Offering
-
Torchlight Announces Closing of Underwritten Public Offering of Common Stock for Gross Proceeds of $27.6 Million
-
USANA Health Sciences Inc. (USNA) PT Raised to $126 at Roth Capital
-
MGM Resorts (MGM) PT Raised to $27 at Roth Capital
-
Assertio Therapeutics (ASRT) Prices 35M Share Registered Direct Offering at $0.98/Sh
-
Assertio Holdings, Inc. Announces Pricing of $34.3 Million Registered Direct Offering
-
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $14 Million
-
McEwen Mining: Registered Direct Offering of Common Stock Completed & Closed
-
McEwen Mining: Registered Direct Offering of Common Stock Completed & Closed
-
Optimizerx Corporation (OPRX) Prices 1.33M Share Common Stock Offering at $49.50/sh
-
OptimizeRx Announces Pricing of Public Offering of Common Stock

